Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
Authors:
- 16 August 2005
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 143 (4) , 282-292
Abstract
Increased pressure in the pulmonary circulation, or pulmonary hypertension, is a common disorder that may complicate various cardiopulmonary conditions, including severe obstructive airways disease and left ventricular dysfunction. An increase in pulmonary arterial pressure that is not due to coexistent cardiopulmonary disease, known as pulmonary arterial hypertension, may occur in the absence of a demonstrable cause (idiopathic or familial); as a complication of systemic conditions, such as connective tissue disease, HIV infection, or chronic liver disease; or as a result of the use of fenfluramine anorexigens, amphetamines, or cocaine. The development of disease-specific therapies for pulmonary arterial hypertension over the past decade underscores the importance of diagnosing pulmonary hypertension early in the course of the condition and implementing a treatment strategy that is based on the condition's cause and severity. In this review, the authors present approaches to the diagnosis and management of pulmonary arterial hypertension, using a hypothetical case to highlight the key management points.Keywords
This publication has 94 references indexed in Scilit:
- Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2European Respiratory Journal, 2004
- Simvastatin Rescues Rats From Fatal Pulmonary Hypertension by Inducing Apoptosis of Neointimal Smooth Muscle CellsCirculation, 2003
- Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvementArthritis & Rheumatism, 2003
- Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β familyJournal of Medical Genetics, 2000
- Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.Journal of Clinical Investigation, 1996
- Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension.Heart, 1994
- Effects of a combination therapy of anticoagulant and vasodilator on the long-term prognosis of primary pulmonary hypertension.Japanese Circulation Journal, 1993
- Comparison of the effects of adenosine and nifedipine in pulmonary hypertensionJACC, 1992
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- PRIMARY PULMONARY HYPERTENSION IN PREGNANCYObstetrical & Gynecological Survey, 1964